Immatics at the Molecular Med TRI-CON Conference (Feb 15-16) in San Francisco, CA, USA
We’re attending the Molecular Med TRI-CON Conference on February 15-16 in San Francisco. Steffen Walter, CSO Immatics US, talks at the Adoptive Cell-Based Cancer Immunotherapy symposium about multivalent Adoptive Cell Therapy using novel XPRESIDENT®-derived targets on Feb 16, 9am.
We're looking forward to interesting and exciting discussions. See the full agenda here: http://bit.ly/2jFDDDt.